Skip to main content

Losartan Potassium and Hydrochlorothiazide

NDC 43547-425 · Solco Healthcare US, LLC

Generic namelosartan potassium and hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength12.5; 100 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

43547-425-03 — 30 TABLET, FILM COATED in 1 BOTTLE (43547-425-03)

43547-425-09 — 90 TABLET, FILM COATED in 1 BOTTLE (43547-425-09)

43547-425-11 — 1000 TABLET, FILM COATED in 1 BOTTLE (43547-425-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43547-391 — olmesartan medoxomil and hydrochlorothiazide, 43547-392 — olmesartan medoxomil and hydrochlorothiazide, 43547-393 — olmesartan medoxomil and hydrochlorothiazide, 43547-397 — Hydrochlorothiazide, 43547-398 — Hydrochlorothiazide, 43547-420 — Lisinopril and Hydrochlorothiazide Tablets, 43547-421 — Lisinopril and Hydrochlorothiazide Tablets, 43547-422 — Lisinopril and Hydrochlorothiazide Tablets, 43547-423 — losartan potassium and hydrochlorothiazide, 43547-424 — losartan potassium and hydrochlorothiazide, 43547-441 — telmisartan and hydrochlorothiazide, 43547-442 — telmisartan and hydrochlorothiazide, 43547-443 — telmisartan and hydrochlorothiazide, 43547-459 — candesartan cilexetil and hydrochlorothiazide, 43547-460 — candesartan cilexetil and hydrochlorothiazide, 43547-461 — candesartan cilexetil and hydrochlorothiazide, 46708-115 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-116 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-117 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-149 — Olmesartan Medoxomil and Hydrochlorothiazide, +1060 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels